141 related articles for article (PubMed ID: 38153518)
41. Postoperative adjuvant chemotherapy is associated with a lower incidence of colorectal adenomas in patients with previous colorectal cancer.
Lee HS; Kim SB; Lee HJ; Park SJ; Hong SP; Cheon JH; Kim WH; Kim TI
Gastrointest Endosc; 2018 Mar; 87(3):688-694.e2. PubMed ID: 28431950
[TBL] [Abstract][Full Text] [Related]
42. Resection rate and effect of postoperative chemotherapy on survival after surgery for colorectal liver metastases.
Figueras J; Valls C; Rafecas A; Fabregat J; Ramos E; Jaurrieta E
Br J Surg; 2001 Jul; 88(7):980-5. PubMed ID: 11442531
[TBL] [Abstract][Full Text] [Related]
43. A systematic overview of chemotherapy effects in colorectal cancer.
Ragnhammar P; Hafström L; Nygren P; Glimelius B;
Acta Oncol; 2001; 40(2-3):282-308. PubMed ID: 11441937
[TBL] [Abstract][Full Text] [Related]
44. [Effect of an oral nutritional supplementation on nutritional status and quality of life in patients with colorectal cancer and postoperative adjuvant chemotherapy: A multi-center prospective randomized control trial].
Yang X; Zhu MW; Xiu DR; Yang Y; Yang GX; Hu WG; Wang ZG; Cui HY; Wei JM
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jun; 23(6):566-571. PubMed ID: 32521976
[No Abstract] [Full Text] [Related]
45. Hepatic resection for colorectal metastases: analysis of prognostic factors.
Ambiru S; Miyazaki M; Isono T; Ito H; Nakagawa K; Shimizu H; Kusashio K; Furuya S; Nakajima N
Dis Colon Rectum; 1999 May; 42(5):632-9. PubMed ID: 10344686
[TBL] [Abstract][Full Text] [Related]
46. Capecitabine versus S-1 as adjuvant chemotherapy for patients with stage III colorectal cancer (JCOG0910): an open-label, non-inferiority, randomised, phase 3, multicentre trial.
Hamaguchi T; Shimada Y; Mizusawa J; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Takiguchi N; Yatsuoka T; Takii Y; Ojima H; Masuko H; Kubo Y; Mishima H; Yamaguchi T; Bando H; Sato T; Kato T; Nakamura K; Fukuda H; Moriya Y
Lancet Gastroenterol Hepatol; 2018 Jan; 3(1):47-56. PubMed ID: 29079411
[TBL] [Abstract][Full Text] [Related]
47. Management and Outcome of Colorectal Cancer Liver Metastases in Elderly Patients: A Population-Based Study.
Booth CM; Nanji S; Wei X; Mackillop WJ
JAMA Oncol; 2015 Nov; 1(8):1111-9. PubMed ID: 26355283
[TBL] [Abstract][Full Text] [Related]
48. Using oral tegafur/uracil (UFT) plus leucovorin as adjuvant chemotherapy in stage II colorectal cancer: a propensity score matching study from Taiwan.
Yu YL; Tseng WK; Liao CK; Yeh CY; Chen HH; Liu YH; Liaw YW; Fan CW
BMC Cancer; 2023 Sep; 23(1):900. PubMed ID: 37749535
[TBL] [Abstract][Full Text] [Related]
49. Chronological Age and Risk of Chemotherapy Nonfeasibility: A Real-Life Cohort Study of 153 Stage II or III Colorectal Cancer Patients Given Adjuvant-modified FOLFOX6.
Laurent M; Des Guetz G; Bastuji-Garin S; Culine S; Caillet P; Aparicio T; Audureau E; Carvahlo-Verlinde M; Reinald N; Tournigand C; Landre T; LeThuaut A; Paillaud E; Canouï-Poitrine F
Am J Clin Oncol; 2018 Jan; 41(1):73-80. PubMed ID: 26669742
[TBL] [Abstract][Full Text] [Related]
50. Laparoscopy as a prognostic factor in curative resection for node positive colorectal cancer: results for a single-institution nonrandomized prospective trial.
Capussotti L; Massucco P; Muratore A; Amisano M; Bima C; Zorzi D
Surg Endosc; 2004 Jul; 18(7):1130-5. PubMed ID: 15156384
[TBL] [Abstract][Full Text] [Related]
51. Efficacy of Early Postoperative Intraperitoneal Chemotherapy After Complete Surgical Resection of Peritoneal Metastasis from Colorectal Cancer: A Case-Control Study from a Single Center.
Park SY; Choi GS; Park JS; Kim HJ; Yang CS; Kim JG; Kang BW
Ann Surg Oncol; 2016 Jul; 23(7):2266-73. PubMed ID: 26951148
[TBL] [Abstract][Full Text] [Related]
52. Prognostic Nutritional Index Predicts Severe Complications, Recurrence, and Poor Prognosis in Patients With Colorectal Cancer Undergoing Primary Tumor Resection.
Tokunaga R; Sakamoto Y; Nakagawa S; Miyamoto Y; Yoshida N; Oki E; Watanabe M; Baba H
Dis Colon Rectum; 2015 Nov; 58(11):1048-57. PubMed ID: 26445177
[TBL] [Abstract][Full Text] [Related]
53. Efficacy and tolerability of adjuvant therapy in ≥70-year-old patients with T3N0M0 colorectal cancer: An observational study.
Sakin A; Yasar N; Sahin S; Arici S; Secmeler S; Can O; Geredeli C; Demir C; Cihan S
J Oncol Pharm Pract; 2020 Apr; 26(3):619-631. PubMed ID: 31366267
[TBL] [Abstract][Full Text] [Related]
54. Factors influencing oncological outcomes in patients who develop pulmonary metastases after curative resection of colorectal cancer.
Kim CH; Huh JW; Kim HJ; Lim SW; Song SY; Kim HR; Na KJ; Kim YJ
Dis Colon Rectum; 2012 Apr; 55(4):459-64. PubMed ID: 22426271
[TBL] [Abstract][Full Text] [Related]
55. Association between poorly differentiated clusters and efficacy of 5-fluorouracil-based adjuvant chemotherapy in stage III colorectal cancer.
Tajima Y; Shimada Y; Kameyama H; Yagi R; Okamura T; Kobayashi T; Kosugi SI; Wakai T
Jpn J Clin Oncol; 2017 Apr; 47(4):313-320. PubMed ID: 28100684
[TBL] [Abstract][Full Text] [Related]
56. Postoperative chemotherapy for colorectal cancer by combining 5-fluorouracil infusion and 1-hexylcarbamoyl-5-fluorouracil administration after curative resection.
Sugimachi K; Maehara Y; Ogawa M; Kakegawa T; Tomita M; Akiyoshi T
Cancer; 1996 Jan; 77(1):36-43. PubMed ID: 8630937
[TBL] [Abstract][Full Text] [Related]
57. Current status of adjuvant chemotherapy for colorectal cancer. Can molecular markers play a role in predicting prognosis?
O'Connell MJ; Schaid DJ; Ganju V; Cunningham J; Kovach JS; Thibodeau SN
Cancer; 1992 Sep; 70(6 Suppl):1732-9. PubMed ID: 1516028
[TBL] [Abstract][Full Text] [Related]
58. Randomized comparative study of surgical adjuvant chemotherapy using 5-fluorouracil and dl-leucovorin with CDDP, 5-FU and dl-leucovorin for advanced colorectal cancer.
Okabe S; Arai T; Yamashita H; Sugihara K; Sasaki T
J Gastroenterol Hepatol; 2004 Jan; 19(1):56-62. PubMed ID: 14675243
[TBL] [Abstract][Full Text] [Related]
59. CIRCULATE-Japan: Circulating tumor DNA-guided adaptive platform trials to refine adjuvant therapy for colorectal cancer.
Taniguchi H; Nakamura Y; Kotani D; Yukami H; Mishima S; Sawada K; Shirasu H; Ebi H; Yamanaka T; Aleshin A; Billings PR; Rabinowitz M; Oki E; Takemasa I; Kato T; Mori M; Yoshino T
Cancer Sci; 2021 Jul; 112(7):2915-2920. PubMed ID: 33931919
[TBL] [Abstract][Full Text] [Related]
60. Indication and efficacy of adjuvant chemotherapy with oral fluoropyrimidines for dukes' B colorectal cancer.
Yoshimatsu K; Umehara A; Ishibashi K; Yokomizo H; Yoshida K; Fujimoto T; Watanabe K; Ogawa K
Anticancer Res; 2006; 26(4B):3089-93. PubMed ID: 16886639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
